Farhad Daighighian

Title: Farhad Daighighian: Innovator in Intraoperative Radiation Probes

Introduction

Farhad Daighighian is a notable inventor based in Santa Monica, California. He has made significant contributions to the field of medical technology, particularly in the development of methods and devices for intraoperative radiation probes. His innovative work aims to enhance the treatment of various medical conditions through advanced detection and therapeutic techniques.

Latest Patents

Daighighian holds a patent for "Methods and devices to expand applications of intraoperative radiation probes." This patent encompasses a range of techniques, including the labeling of diseased or malfunctioning candidate cells with radio pharmaceuticals or fluorescence emitting compounds. The invention allows for the identification of these candidate cells using a probe sensitive to the presence of the label. Furthermore, it includes in situ gene therapy methods that utilize radiation detection probes to locate radio-labeled cells and deliver corrective genes to them. The patent also addresses the identification and treatment of vulnerable plaque in atherosclerotic vessels and diseased myocardial tissue, along with the assessment of treatment efficacy.

Career Highlights

Farhad Daighighian is associated with Intramedical Imaging, LLC, where he continues to innovate in the field of medical imaging and treatment technologies. His work has the potential to significantly improve patient outcomes through more precise and effective treatment methods.

Collaborations

Daighighian has collaborated with notable professionals in his field, including Henry Meyer Daghighian and Barry J Leon. These collaborations have likely contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Farhad Daighighian's contributions to the field of intraoperative radiation probes represent a significant advancement in medical technology. His innovative approaches to identifying and treating diseased tissues have the potential to transform patient care and improve treatment efficacy.